Carroll Financial Associates’s Integra LifeSciences IART Stock Holding History

Carroll Financial Associates’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$7K	Buy	104 +80	+333%	+$5.41K	﹤0.01%	1258
2021 Q3	$1K	Buy	+24	New	+$1.7K	﹤0.01%	1651
2021 Q2	–	Sell	-45	Closed	-$3K	–	1754
2021 Q1	$3K	Hold	45	–	–	﹤0.01%	1445
2020 Q4	$2K	Hold	45	–	–	﹤0.01%	1395
2020 Q3	$2K	Hold	45	–	–	﹤0.01%	1338
2020 Q2	$2K	Hold	45	–	–	﹤0.01%	1355
2020 Q1	$2K	Hold	45	–	–	﹤0.01%	1298
2019 Q4	$2K	Hold	45	–	–	﹤0.01%	1377
2019 Q3	$2K	Hold	45	–	–	﹤0.01%	1340
2019 Q2	$2K	Buy	+45	New	+$2.32K	﹤0.01%	1373
2017 Q2	–	Sell	-19	Closed	–	–	1205
2017 Q1	$0	Sell	19 -9	-32%	-$385	﹤0.01%	1193
2016 Q4	$1K	Hold	28	–	–	﹤0.01%	1090
2016 Q3	$1K	Hold	28	–	–	﹤0.01%	1108
2016 Q2	$1K	Hold	28	–	–	﹤0.01%	1095
2016 Q1	$0	Hold	28	–	–	﹤0.01%	1155
2015 Q4	$0	Hold	28	–	–	﹤0.01%	1117
2015 Q3	$0	Sell	28 -6	-18%	-$188	﹤0.01%	1106
2015 Q2	$1K	Buy	+34	New	+$906	﹤0.01%	1017
2014 Q4	–	Sell	-34	Closed	–	–	788
2014 Q3	$0	Hold	34	–	–	﹤0.01%	877
2014 Q2	$1K	Hold	34	–	–	﹤0.01%	851
2014 Q1	$1K	Hold	34	–	–	﹤0.01%	803
2013 Q4	$0	Hold	34	–	–	﹤0.01%	831
2013 Q3	$0	Hold	34	–	–	﹤0.01%	818
2013 Q2	$0	Buy	+34	New	+$498	﹤0.01%	646

Other funds holding IART

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

EVM

Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Carroll Financial Associates's IART Position: Q4 2021 in Review

Carroll Financial Associates increased its Integra LifeSciences (IART) stake by 333% in Q4 2021, buying an estimated $5.41K and bringing the position to 104 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #1258.

Carroll Financial Associates first reported a position in IART in Q2 2013 and has held it in 24 quarters since. 277 funds tracked by Wall St. Rank hold IART as of Q4 2021.

Carroll Financial Associates held 104 shares of Integra LifeSciences worth $7K as of Q4 2021.
Carroll Financial Associates bought 80 Integra LifeSciences shares in Q4 2021, an estimated $5.41K.
Integra LifeSciences made up ﹤0.01% of Carroll Financial Associates's portfolio in Q4 2021, its #1258 holding.
Carroll Financial Associates first reported a position in Integra LifeSciences in Q2 2013 and has held it in 24 quarters since.
277 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2021.

Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.